WCLC 2026: Lung cancer research highlights

Quality improvement initiative reduces chemotherapy wastage in paediatric oncology in Pakistan

Acyclovir prophylaxis reduces varicella infections in children receiving intensive chemotherapy

Triplet regimen of amivantamab, lazertinib, and pemetrexed showed robust efficacy in advanced EGFR-mNSCLC

Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS

ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas

The evolving treatment landscape in immune thrombocytopenia

ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer

Epcoritamab plus rituximab and lenalidomide improves outcomes across follicular lymphoma subgroups

Epcoritamab improves progression-free survival in relapsed or refractory large B-cell lymphoma

Favezelimab plus pembrolizumab improves progression-free survival in PD-1-refractory classic Hodgkin lymphoma

Blinatumomab replaces intensive chemo in high-risk paediatric ALL, improving survival